FDA Drug Application (017962) for PARLODEL by US PHARMS HOLDINGS I

Back to FDA Applications sponsored by US PHARMS HOLDINGS I

Application Number017962
Product Number001
FormTABLET;ORAL
DosageEQ 2.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePARLODEL
Active IngredientBROMOCRIPTINE MESYLATE

Active IngredientCount
List of drugs with Active Ingredient BROMOCRIPTINE MESYLATE3


Back to FDA Applications sponsored by US PHARMS HOLDINGS I